期刊文献+

肺泡蛋白沉积症继发感染九例临床分析 被引量:8

A clinical analysis of 9 cases of pulmonary alveolar proteinosis with secondary infection
原文传递
导出
摘要 目的 通过分析9例特发性肺泡蛋白沉积症(PAP)继发感染患者的临床资料,以提高陔病的诊治水平。方法 同顾性分析北京协和医院1990年1月至2010年1月因继发感染需要住院诊疗的特发性PAP患者的临床资料。结果 1990年1月1日至2010年1月1日北京协和医院共收治特发性PAP患者97例,男69例,女28例,其中9例㈨继发感染需要住院诊疗,男5例,女4例,年龄22~7l(46.4±14.6)岁。6例曾误诊为间质性肺炎,均用过糖皮质激素治疗(3例仍在使用糖皮质激素,另3例已停用糖皮质激素3~15.5个月)。5例曾接受单侧和(或)双侧肺灌洗,与此次感染相距1个月、2个月、9个月、14个月、24个月不等。发热8例,咳嗽9例,咳痰8例,咯血2例,胸痛1例,肺部听诊有湿哕音1例。影像学以弥漫性磨玻璃影(9例)、空洞影(4例)为主要表现,合并胸腔积液少见(1例)。感染灶均局限在胸腔内:9例均有肺部感染,1例合并胸膜受累。病原学:结核分枝杆菌感染4例,真菌感染3例(白念珠菌、青霉菌及烟曲霉各1例),诺卡菌感染2例(其中1例合并巨细胞病毒感染)。9例患者6例治愈,1例好转,2例死亡。结论 对特发性PAP患者,尤其是州糖皮质激素者,fl;现发热、近期加重的呼吸困难,胸部影像学有空洞、结节影等表现时,需警惕PAP继发感染的可能,尽早获取病原学资料,早期、足疗程治疗可以改善预后。 Objective To describe the clinical characteristics of 9 cases of idiopathic pulmonary alveolar pmteinosis (iPAP) with secondary infections. Method The clinical and radiological data of 9 patients with iPAP and secondary infections admitted into Peking Union Medical College Hospital from 1 st January 1990 to 1st January 2010 were retrospectively analyzed. Results In that period, them were 97 patients of iPAP were admitted in our hospital. There were 9 patients of iPAP with secondary infections ,aged (46.4±14.6)y. There were 5 males and 4 females. Among them, 6 patients were misdiagnosed as interstitial pneumonia and cortieosteroids were given to them. When the infection appeared, cortieosteroids were still given to 3 patients, and the other 3 patients had stopped corticosteroids for 3 to 15 and a half months. Five patients had accepted mono-lung or whole lung lavage before 1,2, 9, 14,24 months. The clinical manifestations were fever ( 8 cases), cough ( 9 cases) , expectoration ( 8 cases), hemoptysis ( 2 cases) , chest pain( l case) and moist rales ( 1 ease). Glass-ground opacities (9 cases) and cavitations (4 case) were the main manifestations of chest radiology. Pleural effusions( 1 case) was not common. The locations of infection was limited in chest:9 cases had puhnonary infection and one case was associated with pleurisy. The infectious pathogens were the acid-fast tubercle bacillus(4 cases), fungus (3 eases, candida albicans, penicillium and aspergillus fumigatus for each one) and norcardia(2 eases, one ease was associated with cytomegalovirus infection). Follow-up: 6 patients were cured, 1 patient was improved and 2 patients were died. Conclusions For patients with iPAP, especially when they had been receiving cortieosteroids, if they had fever and/or recently exaggerated dyspnea, especially whose chest radiology showed nodules and cavitations, the clinicians should be aware of infections diseases for them. Further specific microbiological studies and sufficient therapy should be obtained as quickly as possible.
出处 《中华内科杂志》 CAS CSCD 北大核心 2011年第3期216-220,共5页 Chinese Journal of Internal Medicine
关键词 肺泡蛋白沉积症 感染性疾病 回顾性研究 Pulmonary alveolar proteinosis Infectious diseases Retrospective studies
  • 相关文献

参考文献14

  • 1Huizar I,Kavuru MS.Alveolar proteinosis syndrome:pathogenesis,diagnosis,and management.Curr Opin Pulm Med,2009,15:491-498.
  • 2Uchida K,Beck DC,Yamamoto T,et al.GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.N Engl J Med,2007,356:567-579.
  • 3Greenhill SR,Kotton DN.Pulmonary alveolar proteinosis:a bench-to-bedside story of granulocyte-macrophage colonystimulating factor dysfunction.Chest,2009,136:571-577.
  • 4Trapnell BC,Whitsett JA,Nakata K.Pulmonary alveolar proteinosis.N Engl J Med,2003,349:2527-2539.
  • 5Supena R,Karlin D,Strate R,et al.Pulmonary alveolar proteinosis and Nocardia brain abscess.Report of a case.Arch Neurol,1974,30:266-268.
  • 6Oerlemans WG,Jansen EN,Prevo RL,et al.Primary cerebellar nocardosis and alveolar proteinosis.Acta Neurol Scand,1998,97:138-141.
  • 7Walker DA,McMahon SM.Pulmonary alveolar proteinosis complicated by cerebral abscess:report of a case.J Am Osteopath Assoc,1986,86:447-450.
  • 8Seymour JF,Presneill JJ.Pulmonary alveolar proteinosis:progress in the first 44 years.Am J Respir Crit Care Med,2002,166:215-235.
  • 9张爱武,陶玉倩,方燕南.肺泡蛋白沉积症合并脑脓肿一例[J].中华医学杂志,2008,88(37):2663-2664. 被引量:1
  • 10Byun MK,Kim DS,Kim YW,et al.Clinical features and outcomes of idiopathic pulmonary alveolar proteinosis in Korean population.J Korean Med Sci,2010,25:393-398.

二级参考文献12

  • 1闻胜兰,吴晓虹,应可净,周畔,洪武军.大容量全肺灌洗治疗重度肺泡蛋白沉积症五例分析[J].中华结核和呼吸杂志,2004,27(9):598-600. 被引量:11
  • 2Supena R, Karlin D, Strate R, et al. Pulmonary alveolar proteinosis and Nocardia brain abscess: report of a case. Arch Neurol, 1974,30:266-268.
  • 3Walker DA, McMahon SM. Puhnonary alveolar proteinosis complicated by cerebral abscess : report of a case. J Am Osteopath Assoc, 1986,86:447-450.
  • 4Oerlemans WG, Jansen EN, Prevo RL, et al. Primary cerebellar nocardiosis and alveolar proteinosis. Acta Neurol Scand,1998,97: 138-141.
  • 5Hartmann A, Halvorsen CE, Jenssen T, et al. Intracerebral abscess caused by Nocardia otitidiscaviarum in a renal transplant patientcured by evacuation plus antibiotic therapy. Nephron, 2000,86:79-83.
  • 6JUVET S C, HWANG D, WADDELL T K, et al. Rare lung disease II: pulmonary alveolar proteinosis [J]. Can Respir J, 2008, 15(4) : 203 -210.
  • 7SEYMOUR J F, PRESNEILL J J. Pulmonary alveolar proteinosis: progress in the first 44 years [ J ]. Am J Respir Crit Care Med, 2002,166(2) : 215 -235.
  • 8BEN DOV I, KISHINEVSKI Y, ROZNMAN J,et al. Pulmonary alveolar proteinosis in Israel: ethnic clustering [ J]. Isr Med Assoc J,1999, 1(2) : 75 -78.
  • 9TRAPNELL B C, WHITSETT J A, NAKATA K. Pulmonary alveolar proteinosis [ J ]. N Engl J Med, 2003, 349 ( 26 ) : 2 527 - 2 539.
  • 10RUBINSTEIN I, MULLEN J B, HOFFSTEIN V. Morphologic diagnosis of idiopathic pulmonary alveolar lipoproteinosis - revisited [J]. Arch Intern Med,1988,148(4) : 813 -816.

共引文献16

同被引文献51

  • 1徐凯峰,陈燕,郭子健,朱元珏.肺泡蛋白沉积症患者血清中抗粒-巨噬细胞集落刺激因子抗体等血清学指标的临床意义[J].中华结核和呼吸杂志,2004,27(12):824-828. 被引量:34
  • 2蔡后荣,崔苏阳,金陵,黄贻真,曹彬,王喆妍,母国华,周贤梅.体外循环膜氧合支持下全肺灌洗治疗肺泡蛋白沉积症一例并文献复习[J].中华结核和呼吸杂志,2005,28(4):242-244. 被引量:20
  • 3康健,张宏颖.癌胚抗原与先天免疫[J].国际检验医学杂志,2006,27(9):825-827. 被引量:3
  • 4Patel SM,Sekiguchi H,Reynolds JP,et al. Pulmonary alve-olar proteinosis[J]. Can Respir J,2012,19(4) :243_245.
  • 5Martinez-Moczygemba M,Huston DP. Immune dysregula-tion in the pathogenesis of pulmonary alveolar proteinosis[J]. Curr Allergy Asthma Rep,2010,10(5) :320—325.
  • 6Minakata Y,Kida Y,Nakanishi H,et al. Change in cytoker-atin 19 fragment level according to the severity of pul-monary alveolar proteinosis [J]. Intern Med,2001,40(10):1024-1027.
  • 7Lin FC,Chang GD,Chem MS,et al. Clinical significanceof anti-GM-CSF antibodies in idiopathic pulmonary alve-olar proteinosis[J]. Thorax,2006,61(5) :528-534.
  • 8Trapnell BC,Whitsett JA. GM-CSF regulates pulmonarysurfactant homeostasis and alveolar macrophage-mediatedinnate host defense [J]. Annu Rev Physiol,2002,64:775-802.
  • 9Nakamura Y,Nakamura H,Matsuse A,et al. Interestingcase of pulmonary alveolar proteinosis [J]. Nihon NaikaGakkai Zasshi, 1995,84( 11) : 1909-1911.
  • 10Rosen SH,Castleman B,Liebow AA.Pulmonary alveolar proteinosis [J].N Engl J Med, 1958,258 : 123-1142.

引证文献8

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部